Stephanie Toll, D.O.

Hematology/Oncology

Stephanie-Toll

Provider Name: Stephanie Toll, D.O.

Pediatric Hematology-Oncology Fellowship Director

Academic Appointment: Assistant Professor of Pediatrics

Provider Specialty: Hematology/Oncology

Areas of Clinical Focus:  Neuro-Oncology/Oncology

Areas of Research/Scholarship Focus:  Neuro-Oncology/Oncology

Board Certification(s):  Pediatrics/Pediatric Hematology/Oncology

Primary Practice Name:

Primary Practice Address:

City: Detroit

State: MI

ZIP Code:

Practice Phone Number:

Practice Fax:

Other Practicing Locations:

Accepted Insurance: We accept most types on insurance. Please call to confirm that your carrier is on our list.

Languages Spoken:  English

Medical School:  Philadelphia College of Osteopathic Medicine

Internship:  Nationwide Children's Hospital/Ohio State University

Residency: Nationwide Children's Hospital/Ohio State University

Fellowship: Children's Hospital Los Angeles

Selected Publications:

[1] Toll SA, Tran HN, Cotter J, et al. Sustained response of three pediatric BRAFV600E mutated high-grade gliomas to combined BRAF and MEK inhibitor therapy. Oncotarget. 2019;10(4):551-557. Published 2019 Jan 11. doi:10.18632/oncotarget.26560

[2] Toll SA, Jones MT, Yoshida EJ, Dhall G, Olch AJ, Wong KK. The relationship between ventricular volume and whole-brain irradiation dose in central nervous system germ cell tumors. Pediatr Blood Cancer. 2019;66(12):e28005. doi:10.1002/pbc.28005

[3] Warren M, Hiemenz MC, Schmidt R, Shows J, Cotter J, Toll S, Parham DM, Biegel JA, Mascarenhas L, Shah R. Expanding the spectrum of dicer1-associated sarcomas. Mod Pathol. 2020;33(1):164-174. doi:10.1038/s41379- 019-0366-x

[4] Toll SA, Haltom AR, Cheng D, Maegawa S, Gopalakrishnan V, Khatua S. Medulloblastoma epigenetics and the path to clinical innovation. J Neurooncol. 2020;150(1):35-46. doi:10.1007/s11060-020-03591-9

[5] Toll SA, Peterson C, Kolb B, Poulik JM, Reyes-Mugica M, Sood S, Haridas A, Wang ZJ, Marupudi NI. A Novel Finding of Copy Number Gains in GNAS and Loss of 10q in Child with Malignant Transformation of
Neurocutaneous Melanosis Syndrome: A Case Report and Review of the Literature. JCO Precision Oncology 2021;5:33-38. doi: 10.1200/PO.20.00244

[6] Gorsi HS, Toll SA, Sood S, Miler S, Altinok D, Kumar-Sinha C, Mody R, Yankelevich M. Ongoing Response in a Multiply Relapsed Metastatic Posterior Fossa Ependymoma A After Vorinostat and Concomitant Irradiation. J Pediatr Hematol Oncol. 2021 Apr 28. doi: 10.1097/MPH.0000000000002175.

[7] Ak M, Toll SA, Hein KZ, Colen RR, Khatua S. Evolving Role and Translation of Radiomics and Radiogenomics in Adult and Pediatric Neuro-Oncology. AJNR Am J Neuroradiol. 2021 Oct 14. doi: 10.3174/ajnr.A7297.

[8] Toll SA, Schwartz JD, Gupta S, Khatua S. Targeted Therapy in Pediatric Brain Tumors. In: Horizons in Cancer Research. Vol 78. Hauppauge, NY: Nova Science Publishers; 11788.

Awards/Honors:

Share by: